Biomarin Pharmaceuticals (NQ: BMRN )

64.26 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form S-8
Source: SEC/Edgar
May 24, 2012
Form 8-K
Source: SEC/Edgar
May 23, 2012
Form 8-K
Source: SEC/Edgar
May 08, 2012
Form 8-K
Source: SEC/Edgar
April 25, 2012
Form ARS
Source: SEC/Edgar
March 29, 2012
Form DEFA14A
Source: SEC/Edgar
March 28, 2012
Form DEF 14A
Source: SEC/Edgar
March 22, 2012
Form SC 13G/A
Source: SEC/Edgar
March 11, 2012
Form 8-K
Source: SEC/Edgar
February 21, 2012
Form 8-K
Source: SEC/Edgar
February 15, 2012
Form SC 13G/A
Source: SEC/Edgar
February 13, 2012
Form SC 13G/A
Source: SEC/Edgar
February 13, 2012
Form SC 13G/A
Source: SEC/Edgar
February 12, 2012
Form SC 13G/A
Source: SEC/Edgar
February 12, 2012
Form SC 13G/A
Source: SEC/Edgar
February 09, 2012
Form SC 13G
Source: SEC/Edgar
February 08, 2012
Form 8-K
Source: SEC/Edgar
January 08, 2012
Form 8-K
Source: SEC/Edgar
November 30, 2011
Form 8-K
Source: SEC/Edgar
October 26, 2011
Form 8-K
Source: SEC/Edgar
September 11, 2011
Form CT ORDER
Source: SEC/Edgar
September 05, 2011
Form SC 13G
Source: SEC/Edgar
August 09, 2011
Form 8-K
Source: SEC/Edgar
July 27, 2011
Form 8-K
Source: SEC/Edgar
June 22, 2011
Form 8-K
Source: SEC/Edgar
May 17, 2011
Form 8-K
Source: SEC/Edgar
April 27, 2011
Form SC 13G/A
Source: SEC/Edgar
April 07, 2011
Form ARS
Source: SEC/Edgar
April 03, 2011
Form DEF 14A
Source: SEC/Edgar
March 28, 2011
Form DEFA14A
Source: SEC/Edgar
March 28, 2011
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.